Ra. Brown et al., DIFFERENTIAL-EFFECTS OF CHRONIC CALCIUM-CHANNEL BLOCKER TREATMENT ON THE INOTROPIC RESPONSE OF DIABETIC RAT MYOCARDIUM TO ACUTE ETHANOL EXPOSURE, Life sciences, 59(10), 1996, pp. 835-847
Citations number
44
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
Cardiomyopathy is a consistent feature of diabetic myocardium as well
as in prolonged alcohol consumption. Diabetes-induced myocardial dysfu
nction has been attributed, in part, to calcium overload within indivi
dual myocytes. The present study compares the effectiveness of the cal
cium channel blocker nifedipine (dihydropyridine-type) with verapamil
(phenylalkylamine-type) in reversing myocardial dysfunction and dimini
shing the negative inotropic effect of ethanol on diabetic rat myocard
ium. Wistar rats were made diabetic with streptozotocin (55 mg/kg, IV)
and isolated electrically stimulated papillary muscles were studied u
nder isometric conditions in the absence and presence of clinically re
levant concentrations of ethanol (80-240 mg/dl, ie., 17.4-52.1 mM). Su
bgroups of diabetic and normal animals received daily injections of ve
rapamil or nifedipine 2 weeks after induction of diabetes for 8 weeks.
Untreated diabetic animals exhibited hyperglycemia, hyperlipidemia. r
educed growth, cardiomegaly, and hepatomegaly. Compared to verapamil c
hronic nifedipine treatment normalized or reversed the effects of diab
etes on myocardial mechanical function. The negative inotropic effect
of ethanol was attenuated only in muscles from verapamil-treated diabe
tic animals. Thus, chronic nifedipine treatment may be more effective
than verapamil in reducing hyperglycemia, attenuating both cardiac and
liver enlargement, and restoring myocardial mechanical function, in e
xperimental diabetes. However, chronic verapamil therapy is more effec
tive in diminishing the negative inotropic effect of ethanol on diabet
ic myocardium. These findings may have clinical significance among dia
betic patients who consume alcoholic beverages while receiving long-te
rm calcium blocker therapy.